SCHEMBL7879650

SCHEMBL7879650

Cc1ccc(OCCCN(C)C)c2[nH]c(C(=O)N(C)C(=N)N)cc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
CYP1A2 P05177 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C19 P33261 1/20 0.37
KDM4E B2RXH2 6/20 0.36
HSD17B10 Q99714 2/20 0.36
HPGD P15428 2/20 0.36
THRA P10827 1/20 0.35
THRB P10828 1/20 0.35
HTR1B P28222 1/20 0.35
LMNA P02545 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
HRH3 Q9Y5N1 2/20 0.34
PDGFRB P09619 1/20 0.34
PDGFRA P16234 1/20 0.34
ADRA2A P08913 1/20 0.34
ADRA1D P25100 1/20 0.34
CHEK2 O96017 1/20 0.33
MEN1 O00255 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7881179 0.99 ALDH1A1 (0.38) ALDH1A1SMN1; SMN2CYP1A2CYP2D6CYP2C19
Hydrochloric Acid SCHEMBL7879936 0.94 KDM4E (0.37) ALDH1A1SMN1; SMN2CYP1A2CYP2D6KDM4E
SCHEMBL7879681 0.91 ALDH1A1 (0.38) ALDH1A1CYP1A2CYP2D6CYP2C19KDM4E
SCHEMBL7884302 0.91 KDM4E (0.35) ALDH1A1KDM4EHSD17B10HPGDHTR1B
Hydrochloric Acid SCHEMBL7884697 0.90 ALDH1A1 (0.38) ALDH1A1CYP1A2CYP2D6CYP2C19KDM4E
SCHEMBL7882187 0.90 KDM4E (0.45) ALDH1A1KDM4EHSD17B10HPGDTHRA
Hydrochloric Acid SCHEMBL7884328 0.90 KDM4E (0.35) ALDH1A1KDM4EHSD17B10HPGDMEN1
Hydrochloric Acid SCHEMBL7884762 0.89 KDM4E (0.40) ALDH1A1SMN1; SMN2CYP1A2CYP2D6CYP2C19
Hydrochloric Acid SCHEMBL8633721 0.89 KDM4E (0.40) ALDH1A1SMN1; SMN2CYP1A2CYP2D6CYP2C19
Hydrochloric Acid SCHEMBL7881514 0.89 KDM4E (0.44) ALDH1A1KDM4EHSD17B10HPGDTHRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6248772-B1 HYPOTENSIVE AGENTS; ANTIARRHYTHMIA AGENTS; ANTIDIABETIC AGENTS; ANTIPROLIFERATIVE AGENTS SUMITOMO PHARMACEUTICALS CO., LTD. (JP) 2001-06-19 US disclosed
US-6169107-B1 USEFUL FOR THE TREATMENT AND PREVENTION OF DISEASES CAUSED BY INCREASED SODIUM/PROTON (NA.SUP.+ /H.SUP.+) EXCHANGER ACTIVITY, FOR EXAMPLE, HYPERTENSION, ARRHYTHMIA, ANGINA PECTORIS, CARDIAC HYPERTROPHY, DIABETES MELLITUS SUMITOMO PHARMACEUTICAL CO., LTD. (JP) 2001-01-02 US disclosed
EP-0622356-B1 Indoloylguanidine derivatives as inhibitors of sodium-hydrogen exchange SUMITOMO PHARMA (JP) 1998-07-01 EP disclosed
EP-0708091-A2 Indoloylguanidine derivatives SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1996-04-24 EP disclosed
EP-0622356-A1 Indoloylguanidine derivatives as inhibitors of sodium-hydrogen exchange SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 1994-11-02 EP disclosed